Newborn 17-OHP Screening Price | Lahalak Platform
Essential newborn screening for Congenital Adrenal Hyperplasia, ensuring early intervention and protecting your baby from serious salt-wasting crises.
Scientific name: Newborn 17-Hydroxyprogesterone (17-OHP) Screening
A newborn screening test measures the blood level of 17-hydroxyprogesterone (17-OHP), the primary hormone that accumulates in the blood when there is a deficiency of the enzyme 21-hydroxylase. This deficiency is the most common cause (over 90%) of congenital adrenal hyperplasia (CAH), a genetic disorder that affects the production of the hormones c...
Included Services
- Blood samples were taken from the newborn's heel according to standard medical protocol.
- Measure the level of 17-hydroxyprogesterone (17-OHP) in the blood using an immunoassay technique (such as ELISA or CLIA).
- Evaluate the result taking into account gestational age and weight (to avoid false positives in premature infants).
- Perform a rapid confirmatory test using a more specific method (such as HPLC or mass spectrometry) if the initial result is positive.
- Urgent notice and guidance to the family, pediatrician, and pediatric endocrinologist.
- Consult interpretation of comprehensive results with endocrine specialist for children.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- There is no fasting requirement for the baby, but it is preferable to take the sample 48-72 hours after birth, as 17-OHP levels are elevated.
- For premature or low-birth-weight babies, laboratories typically use their own higher threshold values or mathematical formulas to adjust the value according to gestational age and weight.
- The child's data must be filled out accurately (gestational age in weeks, weight, age in hours, any medications the mother is receiving if she is breastfeeding).
- If the child has received a blood transfusion, it may interfere with the result, and the laboratory should be informed.